HomeCONGRESS

CONGRESS

View Category
Acute coronary syndromes

DEFINE FLAIR and IFR SWEDEHEART: Safety in Revascularization Based on FFR and iFR in Both Stable and ACS Patients

The safety of physiology-based coronary revascularisation has been supported by evidence for years now. DEFER (1998-2001) was...
solaci -
Learn More
Coronary disease

DESSOLVE III: Xience vs. MiStent

The MiStent device is made of cobalt-chromium, with struts of up to 64 µm thick. It is coated...
solaci -
Learn More
DAY 1

REPRISE III: Lotus and CoreValve Compared in High-Risk or Inoperable Patients

The efficacy of transcatheter aortic valve replacement (TAVR) has been well-established. However, its limitations include suboptimal deployment...
solaci -
Learn More
Antiplatelet

TOPIC: Benefits of Switching Dual Antiplatelet Therapy in Patients with ACS

Newer P2Y12 blockers are the front-line treatment and dual antiplatelet therapy is indicated for 1 year after acute...
solaci -
Learn More
Euro PCR 2017

Euro PCR 2017

Here you will find the highlights of Euro PCR 2017, held on May 16-19 in Paris, France. If you cannot...
solaci -
Learn More
ACC 2017 HIGHLIGHTS

Closing off the Appendage While Performing Cardiac Surgery Results in a Reduction in Risk of Embolic Stroke

Closing off the left appendage as an add-on procedure while performing other cardiac surgery in patients with...
solaci -
Learn More
ACC 2017 HIGHLIGHTS

Infarction in Cariogenic Shock: Prioritizing the Use of Impella Could Improve Survival

This small study suggests the early use of Impella ventricular support device in patients undergoing AMI complicated...
solaci -
Learn More
ACC 2017 HIGHLIGHTS

FFR-Guided ACS Revascularization Apparently Superior to Culprit Vessel Treatment

Using fractional flow reserve (FFR) to guide revascularization of all functionally significant lesions in the setting of...
solaci -
Learn More